CARM1 and non-small cell lung carcinoma: found that circHMGB2 promoted the proliferation of NSCLC and remodeled the TME, limiting the efficacy of PD-1 blockade in NSCLC treatment via modulating the miR-181a-5p/CARM1 axis (125).